1. The analysis of foveal microvascular anomalies in retinopathy of prematurity after anti-vascular endothelial growth factor therapy using optical coherence tomography angiography.
- Author
-
Liu W, Guo L, Cai Y, Xu H, Linghu D, Zhu X, Cheng Y, Deng X, Zhao M, Shi X, and Liang J
- Subjects
- Humans, Male, Female, Cross-Sectional Studies, Intravitreal Injections, Infant, Newborn, Infant, Recombinant Fusion Proteins therapeutic use, Retrospective Studies, Child, Preschool, Fundus Oculi, Microvessels diagnostic imaging, Microvessels drug effects, Microvessels pathology, Retinopathy of Prematurity drug therapy, Retinopathy of Prematurity diagnosis, Tomography, Optical Coherence methods, Fovea Centralis blood supply, Fovea Centralis diagnostic imaging, Angiogenesis Inhibitors therapeutic use, Ranibizumab therapeutic use, Ranibizumab administration & dosage, Fluorescein Angiography methods, Vascular Endothelial Growth Factor A antagonists & inhibitors, Retinal Vessels diagnostic imaging, Retinal Vessels pathology, Visual Acuity
- Abstract
Background: To investigate the quantitative vascular and structural differences in the foveal region of the eyes in retinopathy of prematurity children with or without anti-vascular endothelial growth factor (VEGF) therapy and healthy children using optical coherence tomography angiography (OCTA)., Methods: This cross-sectional study analyzed 75 eyes from 44 subjects, categorized into four groups: ROP children treated with Conbercept or Ranibizumab, spontaneously regressed ROP, and healthy age-matched children. Using spectral-domain OCT and OCTA, we assessed parameters like central foveal thickness (CFT), foveal avascular zone (FAZ), superficial/deep capillary plexus (SCP/DCP), and choroidal vessel density (VD) at the fovea. Correlations between foveal microvasculature, preterm status and visual acuity were evaluated., Results: Significant differences were found in FAZ area, CFT, and VD-SCP (parafoveal) among the groups. The FAZ area was smaller in ROP children (with/without treatment) than in healthy counterparts(p = 0.009). CFT was higher in the Ranibizumab and spontaneously regressed groups compared to healthy ones (p = 0.043, p = 0.037), while Conbercept-treated children showed no significant difference (p = 0.886). Foveal VD trends were higher in groups A, B, and C compared to group D. FAZ area correlated negatively with CFT, VD-SCP (foveal), and VD-DCP (foveal) (p < 0.001, p < 0.001, p = 0.001), and positively with choroidal VD (p = 0.012). CFT showed positive correlations with VD-SCP (foveal) and VD-DCP (foveal) (p = 0.003, p = 0.001)., Conclusion: ROP children exhibit a smaller FAZ area compared to healthy group, with no significant difference noted when comparing the use of different anti-VEGF agents. ROP children have a thicker CFT than healthy children, except for those treated with Conbercept. Furthermore, microvascular irregularities were correlated with central foveal thickness., Competing Interests: Declarations Ethics approval and consent to participate This study was approved by the Ethical Committee of Peking University People’s Hospital.It was conducted according to the guidelines of the Declaration of Helsinki. Informed consent was obtained from all participants’ guardians. Consent for publication Not Applicable. Competing interests The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF